Redmond Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-21,310
Closed -$1.73M 163
2017
Q3
$1.73M Sell
21,310
-305
-1% -$23.3K 0.79% 46
2017
Q2
$1.53M Sell
21,615
-7,680
-26% -$511K 0.72% 56
2017
Q1
$1.99M Sell
29,295
-45
-0.2% -$3.16K 1.02% 30
2016
Q4
$2.1M Buy
29,340
+773
+3% +$57.5K 0.97% 32
2016
Q3
$2.26M Sell
28,567
-105
-0.4% -$8.53K 1.11% 24
2016
Q2
$2.39M Sell
28,672
-114
-0.4% -$10.1K 1.19% 22
2016
Q1
$2.64M Sell
28,786
-17,319
-38% -$1.56M 1.33% 16
2015
Q4
$4.67M Buy
46,105
+466
+1% +$48.5K 2.53% 5
2015
Q3
$4.48M Sell
45,639
-27
-0.1% -$3K 2.38% 4
2015
Q2
$5.35M Sell
45,666
-176
-0.4% -$19.2K 2.64% 4
2015
Q1
$4.5M Sell
45,842
-154
-0.3% -$15.6K 2.27% 5
2014
Q4
$4.34M Sell
45,996
-1,452
-3% -$150K 2.16% 7
2014
Q3
$5.05M Buy
47,448
+3,355
+8% +$329K 2.62% 4
2014
Q2
$3.66M Buy
44,093
+21,278
+93% +$1.66M 1.79% 7
2014
Q1
$1.62M Sell
22,815
-114
-0.5% -$8.94K 0.86% 42
2013
Q4
$1.72M Sell
22,929
-1,096
-5% -$76.3K 0.92% 36
2013
Q3
$1.51M Sell
24,025
-6,775
-22% -$405K 0.88% 46
2013
Q2
$1.58M Buy
+30,800
New +$1.61M 1.17% 33

Other funds holding GILD

Redmond Asset Management's GILD Position: Q4 2017 in Review

Redmond Asset Management sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 21,310 shares — an estimated $1.73M sold.

Redmond Asset Management first reported a position in GILD in Q2 2013 and held it in 18 quarters. The position peaked at $5.35M in Q2 2015. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Redmond Asset Management reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Redmond Asset Management sold 21,310 Gilead Sciences shares in Q4 2017, an estimated $1.73M.
  • Redmond Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 18 quarters.
  • Redmond Asset Management's Gilead Sciences position peaked at $5.35M in Q2 2015.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Redmond Asset Management's 13F filing for Q4 2017, filed 2 Feb 2018.